标题
YAP induces high-grade serous carcinoma in fallopian tube secretory epithelial cells
作者
关键词
-
出版物
ONCOGENE
Volume 35, Issue 17, Pages 2247-2265
出版商
Springer Nature
发表日期
2015-09-14
DOI
10.1038/onc.2015.288
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma
- (2015) Amir A. Jazaeri et al. NEOPLASIA
- YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors
- (2014) David Fu et al. ENDOCRINE-RELATED CANCER
- A genetically engineered ovarian cancer mouse model based on fallopian tube transformation mimics human high-grade serous carcinoma development
- (2014) Cheryl A Sherman-Baust et al. JOURNAL OF PATHOLOGY
- Ovarian Cancer Cell Line Panel (OCCP): Clinical Importance of In Vitro Morphological Subtypes
- (2014) Corine M. Beaufort et al. PLoS One
- Coming into focus: the nonovarian origins of ovarian cancer
- (2013) L. Dubeau et al. ANNALS OF ONCOLOGY
- Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
- (2013) Ruth Perets et al. CANCER CELL
- CDK1 Phosphorylation of YAP Promotes Mitotic Defects and Cell Motility and Is Essential for Neoplastic Transformation
- (2013) S. Yang et al. CANCER RESEARCH
- The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells
- (2013) Hui Cai et al. Cell Communication and Signaling
- The Hippo pathway: regulators and regulations
- (2013) F.-X. Yu et al. GENES & DEVELOPMENT
- FGFR signalling in women's cancers
- (2013) Abbie E. Fearon et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
- (2013) Randy Johnson et al. NATURE REVIEWS DRUG DISCOVERY
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- The G-protein-coupled estrogen receptor agonist G-1 suppresses proliferation of ovarian cancer cells by blocking tubulin polymerization
- (2013) C Wang et al. Cell Death & Disease
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Mucinous adenocarcinoma developed from human fallopian tube epithelial cells through defined genetic modifications
- (2012) Weiwei Shan et al. CELL CYCLE
- Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP
- (2012) Y. Liu-Chittenden et al. GENES & DEVELOPMENT
- Cancer of the ovary, fallopian tube, and peritoneum
- (2012) Jonathan S. Berek et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Primary culture and immortalization of human fallopian tube secretory epithelial cells
- (2012) Alison M Karst et al. Nature Protocols
- Transforming Growth Factor Alpha (TGFα) Regulates Granulosa Cell Tumor (GCT) Cell Proliferation and Migration through Activation of Multiple Pathways
- (2012) Cheng Wang et al. PLoS One
- High-grade serous ovarian cancer arises from fallopian tube in a mouse model
- (2012) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
- (2011) Vito Guagnano et al. JOURNAL OF MEDICINAL CHEMISTRY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
- (2011) X Zhang et al. ONCOGENE
- Modeling high-grade serous ovarian carcinogenesis from the fallopian tube
- (2011) A. M. Karst et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Shortened Telomeres in Serous Tubal Intraepithelial Carcinoma: An Early Event in Ovarian High-grade Serous Carcinogenesis
- (2010) Elisabetta Kuhn et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
- (2010) C. A. Hall et al. CANCER RESEARCH
- The Hippo Signaling Pathway in Development and Cancer
- (2010) Duojia Pan DEVELOPMENTAL CELL
- Expression of E-Cadherin and N-Cadherin in Perinatal Hamster Ovary: Possible Involvement in Primordial Follicle Formation and Regulation by Follicle-Stimulating Hormone
- (2010) Cheng Wang et al. ENDOCRINOLOGY
- The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
- (2010) K.-P. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Incidence of Ovarian, Peritoneal, and Fallopian Tube Carcinomas in the United States, 1995-2004
- (2009) M. T. Goodman et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas
- (2009) Celestine S Tung et al. MODERN PATHOLOGY
- YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway
- (2009) Jianmin Zhang et al. NATURE CELL BIOLOGY
- Spheroid-based drug screen: considerations and practical approach
- (2009) Juergen Friedrich et al. Nature Protocols
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- Effect of bFGF on invasion of ovarian cancer cells through the regulation of Ets-1 and urokinase-type plasminogen activator
- (2009) Ting Li et al. PHARMACEUTICAL BIOLOGY
- Yes-associated protein (YAP) functions as a tumor suppressor in breast
- (2008) M Yuan et al. CELL DEATH AND DIFFERENTIATION
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
- (2008) Keren Levanon et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now